99.0%Min. Cetrorelix Acetate Lyophilized Powder Peptide CAS No.: 130143-01-0; 120287-85-6 Research Chemical

• CAS No.: 130143-01-0
• Formula: C70h92cln17o14
• EINECS: 120287-85-6
• Environmental Protection: Yes
• Certification: ISO9001
• Color: White
• Model NO.: Cetrorelix
• Classification: Peptides
• Function: Infertility
• Appearance: Powder
• Transport Package: 10vials Per Box
• Specification: 2mg
• Trademark: Runyan
• Origin: Korea
• Production Capacity: 10000pieces/Month

Product Description

High Purity 99.0%min. Cetrorelix Acetate Lyophilized powder Peptide CAS NO.:130143-01-0 ; 120287-85-6 Research Chemical

Product Information:
INCI Name: Cetrorelix Acetate
Cas No:  130143-01-1; 120287-85-6
Molucular Formula:   C70H92ClN17O14
Molecular Weight:    1431.04 
Sequence: Ac-D-Nal1-D-Cpa2-D-Pal3-Ser4-Tyr5- D-Cit6-Leu7-Arg8-Pro9-D -Ala10-NH2
Purity: >99%
Source: Synthetic
Grade: Cosmetic
Stability: Stable
Solubility: Slightly soluble in water
Formulation: Available for your reference, please contact us
MSDS and COA: Available for your reference, please contact us
Appearance: White Lyophilized powder
Storage:After reconstitution store at 2°C - 8°C
 

Application
Cetrorelix acetate is the acetic acid salt of cetrorelix. A gona dotrophin-releasing hor mone (Gn RH) antagonist, it is used for treatment of infertility and of hormone-sensitive cancers of the prostate and breast. It has a role as a Gn RH antagonist and an antineoplastic agent. It is an oligopeptide and an acetate salt. It contains a cetrorelix.
Cetrorelix acetate is a synthetic decapeptide, which is mainly used in assisted reproductive technology to prevent premature ovulation in patients with controlled ovarian stimulation. It is a gona dotropin-releasing hor mone (Gn RH) antagonist that can compete with endogenous LH RH to bind to receptors on the pituitary cell membrane, thereby inhibiting the secretion of luteini 'zing hor mone (L H) and follicle stimulating hor mone (F S H) by the pituitary in a dose-dependent manner .
Function
Cetrorelix acetate is a kind of gona dotropin releasing horvmone (Gn RH) antagonist. This product competes with endogenous Gn RH for receptors on pituitary cells, thus inhibiting the release of endogenous (L H) fschemicalbook, delaying the appearance of L H peak, and thus controlling ovulation. The effect of this product is dose-dependent, and the inhibition is direct, and maintained by continuous treatment, without causing the activity of luteinin receptor to rise at the initial stage and then down regulate.
 

 

Clarify:

Our peptides is just for Reseach&Lab use,not used on Human body.

The potential efficacy and application involved in the product introduction are all from the published literature, which has not been evaluated by the State Food and Drug Administration, and are only for reference, not for actual basis.